Still, we’re seeing progress in this space. Recently, the Food and Drug Administration (FDA) approved the prescription of a new non-opioid pill for moderate-to-severe acute pain. The medication, ...

CHICAGO, IL—Replacing aspirin with indobufen in the dual antiplatelet (DAPT) regimen for patients without elevated cardiac troponin after successful drug-eluting stent implantation results in a lower ...

Reteplase appears to be another safe and effective thrombolytic option for the treatment of acute ischemic stroke, according to results from the randomized RAISE trial. When given within the first 4.5 ...

Each year, there’s a narrow window when families can join or change their health insurance plan. But once open enrollment closes, the opportunity is gone until the next year, leaving many families ...